FDA
-
-
-
-
-
-
-
Palvella Therapeutics hires Jennifer McDonough as senior VP
-
-
-
-
-
-
-
Krystal Biotech (KRYS) PT Raised to $306 at TD Cowen
-
-
-
-
-
-
-
Krystal Biotech receives FDA platform technology designation for HSV-1 vector
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Krystal Biotech (KRYS)
-
-
-
-
-
-
-
Jeune Announces Positive Results and Significant Aesthetic Improvements from Phase 1 Study of KB304 for Moderate to Severe Wrinkles of the Décolleté
-
-
-
-
-
-
-
Krystal Biotech (KRYS) Announces European Commission Approval of VYJUVEK for the Treatment of Dystrophic Epidermolysis Bullosa
-
-
-
-
-
-
-
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
-
330,674 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

